Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 11/20 | 0.64 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.53 |
| ▸ | GLP1R | P43220 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11011526 | 1.00 | NOD1 (0.64) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL359523 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL539142 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL11102827 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL11102825 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2343614 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2340732 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL19499060 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2344383 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2341081 | 0.99 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| US-20250339370-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AVANTOR PERFORMANCE MATERIALS, LLC (US) | 2025-11-06 | — | — | US | disclosed |
| US-10786437-B2 | Composition for cosmetics and cosmetics comprising same | AJINOMOTO CO., INC (JP) | 2020-09-29 | — | — | US | disclosed |
| US-10736826-B2 | Cream-like composition | AJINOMOTO CO., INC. (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20190133897-A1 | CREAM-LIKE COMPOSITION | AJINOMOTO CO., INC. (JP) | 2019-05-09 | — | — | US | disclosed |
| CN-108976147-A | The positive positive hexanoyl basic amino acid of hexanoyl amino first cyclic amide base of amino, synthesis, activity and application | 首都医科大学 | 2018-12-11 | — | — | CN | disclosed |
| US-RE37971-E1 | Acylation of proteins, specifically insulin and its analogs, with a fatty acid | ELI LILLY AND COMPANY | 2003-01-28 | — | — | US | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
| EP-0139481-A2 | Surface modification using N-acyl lysines | AJINOMOTO CO., INC. (JP) | 1985-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339370-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AADAT, KYNU, PNISR | NOD1 3917/4885SLC6A5 3122/4885EPHX2 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.